Zylox-Tonbridge Medical Technology Co., Ltd.

Informe acción SEHK:2190

Capitalización de mercado: HK$3.5b

Salud financiera de hoja de balance de Zylox-Tonbridge Medical Technology

Salud financiera controles de criterios 4/6

Zylox-Tonbridge Medical Technology tiene un patrimonio de los accionistas total de CN¥3.1B y una deuda total de CN¥75.0M, lo que sitúa su ratio deuda-patrimonio en 2.4%. Sus activos y pasivos totales son CN¥3.5B y CN¥376.9M respectivamente.

Información clave

2.4%

Ratio deuda-patrimonio

CN¥75.00m

Deuda

Ratio de cobertura de interesesn/a
EfectivoCN¥1.17b
PatrimonioCN¥3.11b
Total pasivoCN¥376.86m
Activos totalesCN¥3.49b

Actualizaciones recientes sobre salud financiera

Recent updates

Market Participants Recognise Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Revenues Pushing Shares 27% Higher

Oct 02
Market Participants Recognise Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Revenues Pushing Shares 27% Higher

Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business

Sep 27
Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business

Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon

Apr 23
Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon

Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate

Jan 18
Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate

Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?

Sep 21
Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?

There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price

Aug 03
There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price

We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Jun 30
We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?

Mar 08
Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?

We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Jan 19
We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

Jul 06
Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely

Jan 27
We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely

Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

Oct 05
Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (CN¥1.4B) de 2190 superan a sus pasivos a corto plazo (CN¥358.6M).

Pasivo a largo plazo: Los activos a corto plazo de 2190 (CN¥1.4B) superan a sus pasivos a largo plazo (CN¥18.3M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: 2190 tiene más efectivo que su deuda total.

Reducción de la deuda: No se dispone de datos suficientes para determinar si el ratio deuda-patrimonio de 2190 se ha reducido en los últimos 5 años.

Cobertura de la deuda: La deuda de 2190 está bien cubierta por el flujo de caja operativo (294.7%).

Cobertura de intereses: Datos insuficientes para determinar si los pagos de intereses de 2190 sobre su deuda están bien cubiertos por el EBIT.


Hoja de balance


Descubre empresas con salud financiera